LEO Pharma Presents DELTA 3 Trial Data at 2024 AAD Meeting
LEO Pharma A/S, a global leader in medical dermatology, today presented for the first time key results from the DELTA 3 trial of delgocitinib cream, an investigational topical pan-Janus kinase (JAK)-inhibitor, at the 82nd American Academy of Dermatology (AAD) Congress in…
UnitedHealth Group’s Change Healthcare Cyberattack Update
UnitedHealth Group reports significant strides in mitigating the effects of the cyberattack on the U.S. health system and the Change Healthcare infrastructure. Efforts focus on ensuring seamless access to care and medications for consumers and providers impacted by the attack.…
Signifier Medical Study Explores Neuromuscular Stimulation for Sleep Apnea
Signifier Medical Technologies, based in Boston, announces the publication of a study titled “Cost-Effectiveness of Neuromuscular Electrical Stimulation for the Treatment of Mild Obstructive Sleep Apnea” in The International Journal of Technology Assessment in Health Care. Led by Drs. Shan…
Thermo Fisher Unveils CorEvitas Registry for Pustular Psoriasis
Thermo Fisher Scientific Inc., a global leader in scientific solutions, has introduced a new CorEvitas syndicated clinical registry focusing on generalized pustular psoriasis (GPP). The registry, now open for enrollment, fills a crucial gap in real-world evidence (RWE) concerning clinical…
Findhelp, Foothold Partner for Medicaid 1115 Waiver Program
“Findhelp, a leading closed-loop referral management software company, is pleased to announce a partnership with Foothold Technology, a top provider of Human Services Electronic Health Record (EHR) and Care Coordination software. This collaboration aims to integrate mental and behavioral health…
Timber Pharma Presents TMB-001 Results for Congenital Ichthyosis
LEO Pharma, a parent company of Timber Pharmaceuticals, Inc., presents initial findings from the ASCEND trial in a late-breaking session at the 2024 American Academy of Dermatology (AAD) Annual Meeting. The study provides a preliminary assessment of safety, efficacy, and…
Incyte Reveals Late-Breaking Phase 2 Data on Povorcitinib for Prurigo Nodularis
Incyte (Nasdaq:INCY) disclosed findings from a Phase 2 trial examining povorcitinib (INCB54707), an oral JAK1 inhibitor’s effectiveness and safety among adult patients with prurigo nodularis (PN). These results were presented during a late-breaking oral session (Session: S050 – Late-Breaking Research:…
Alnylam’s KARDIA-2 Study Shows Significant Blood Pressure Reductions with Zilebesiran
Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics company, has announced positive results from the Phase 2 KARDIA-2 trial of zilebesiran, an RNAi therapeutic designed to treat hypertension by targeting liver-expressed angiotensinogen (AGT). The trial met its primary endpoint,…
Tandem Diabetes Care Prices $275M Convertible Senior Notes Offering
Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a global leader in insulin delivery and diabetes technology, has announced the pricing of $275.0 million aggregate principal amount of 1.50% Convertible Senior Notes due 2029 (the “notes”) in a private placement. This offering,…
LivaNova Prices $300M Convertible Senior Notes Offering
LivaNova PLC (Nasdaq: LIVN), a prominent player in the medical technology sector, has announced the pricing of $300 million aggregate principal amount of 2.50% convertible senior notes due 2029 (referred to as the “notes”). These notes will be issued in…
e4life: Electromagnetic Waves Combat Viruses with Over 90% Success
Amidst projections of the smart home market reaching $345.6 billion by 2032 (Source: IMARC Group), the sector of home healthcare and air purification devices is rapidly growing. Fueled by the COVID-19 pandemic, these products now comprise 11% of the market.…
Aktana Launches Next-Gen Omnichannel Tools for Medtech
Aktana, Inc., a pioneer in intelligent customer engagement for the life sciences and medical sector, unveils “Aktana for MedTech,” offering AI-driven tools to enhance representative field execution, account coordination, and medical education programs. Aktana, Inc., a leader in intelligent customer…